Pancreatic Cancer Research

ResearcherTongji UniversityNo recent work listed

Xiaoping Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1592-2353; OpenAlex author ID A5100363153. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
16
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 3 papers · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 7

  1. GAS41 mediates proliferation and GEM chemoresistance via H2A.Z.2 and Notch1 in pancreatic cancer. Last author DOI 10.1007/s13402-022-00675-8↗
  2. Transcatheter Arterial Infusion Combined With Radioactive Particles in the Treatment of Advanced Body/Tail Pancreatic Cancer: A Retrospective Cohort Study. Last author DOI 10.1097/mpa.0000000000001851↗
  3. Long noncoding RNA MIR155HG facilitates pancreatic cancer progression through negative regulation of miR-802. Last author DOI 10.1002/jcb.29060↗
  4. PPM1D exerts its oncogenic properties in human pancreatic cancer through multiple mechanisms. Co-author DOI 10.1007/s10495-015-1211-4↗
  5. Downregulation of Smurf2 ubiquitin ligase in pancreatic cancer cells reversed TGF-β-induced tumor formation. Co-author DOI 10.1007/s13277-016-5432-0↗
  6. MicroRNA-182 promotes pancreatic cancer cell proliferation and migration by targeting β-TrCP2. Co-author DOI 10.1093/abbs/gmw105↗
  7. Differential gene expression of the key signalling pathway in para-carcinoma, carcinoma and relapse human pancreatic cancer. Co-author DOI 10.1002/cbf.3009↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shilong Han · 3 shared papers, 2016–2022 · strength 0.31
  2. Maoquan Li · 3 shared papers, 2016–2022 · strength 0.31
  3. Rui Liu · 1 shared paper, 2022 · strength 0.15
  4. Xiaojun Zhang · 1 shared paper, 2022 · strength 0.15
  5. Kaixing Ai · 2 shared papers, 2016 · strength 0.13
  6. Bo Wu · 2 shared papers, 2016 · strength 0.13
  7. Yan Qin · 1 shared paper, 2019 · strength 0.12
  8. Yuliang Li · 1 shared paper, 2021 · strength 0.10
  9. Wujie Wang · 1 shared paper, 2021 · strength 0.10
  10. Jun Chen · 1 shared paper, 2021 · strength 0.10
  11. Huirong Xu · 1 shared paper, 2021 · strength 0.10
  12. Shi Wang · 1 shared paper, 2016 · strength 0.06
  13. Da Fu · 1 shared paper, 2014 · strength 0.04
  14. Yu‐Shui Ma · 1 shared paper, 2014 · strength 0.04
  15. Zhengyan Chang · 1 shared paper, 2014 · strength 0.04
  16. Wenping Li · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.